Discovering DNA encodes heredity and prions are infectious proteins

Annual Review of Genetics

Volumn 40, Issue , 2006, Pages 25-45

  Prusiner, Stanley B ^a   McCarty, Maclyn ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Bioassays; Biological information; Genes; Nucleic acids; Prions; Proteins; Purification

Indexed keywords

DNA; PRION PROTEIN; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOASSAY; COLONY FORMATION; CONTROLLED STUDY; DNA STRUCTURE; INCUBATION TIME; INFECTION; INOCULATION; MOUSE; NONHUMAN; PRION; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; REVIEW; SCRAPIE; STREPTOCOCCUS PNEUMONIAE; SYRIAN HAMSTER;

ANIMALS; BIOLOGICAL ASSAY; CRICETINAE; DNA; HEREDITY; HISTORY, 20TH CENTURY; HUMANS; MICE; MODELS, BIOLOGICAL; MOLECULAR BIOLOGY; PRIONS; SCRAPIE; TRANSFORMATION, GENETIC;

CRICETINAE; FUNGI; STREPTOCOCCUS PNEUMONIAE;

EID: 33845681207     PISSN: 00664197     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genet.40.121505.133522     Document Type: Review

References (123)

1. Akowitz A, Sklaviadis T, Manuelidis L. 1994. Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease. Nucleic Acids Res. 22:1101-7
2. Alloway JL. 1932. The transformation in vitro of R pneumococci into S forms of different specific types by the use of filtered pneumococcus extracts. J. Exp. Med. 55:91-99
3. Alloway JL. 1933. Further observations on the use of pneumococcus extracts in effecting transformation of type in vitro. J. Exp. Med. 57:265-78
4. Alper T, Cramp WA, Haig DA, Clarke MC. 1967. Does the agent of scrapie replicate without nucleic acid? Nature 214:764-66
5. Avery OT, MacLeod CM, McCarty M. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a deoxyribonucleic acid fraction isolated from pneumococcus type III. J. Exp. Med. 79:137-57
6. Baskakov IV, Legname G, Baldwin MA, Prusiner SB, Cohen FE. 2002. Pathway complexity of prion protein assembly into amyloid. J. Biol. Chem. 277:21140-48
7. Basler K, Oesch B, Scott M, Westaway D, Wälchli M, et al. 1986. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46:417-28
8. Bastian FO, Foster JW. 2001. Spiroplasma sp. 16S rDNA in Creutzfeldt-Jakob disease and scrapie as shown by PCR and DNA sequence analysis. J. Neuropathol. Exp. Neurol. 60:613-20
9. Beadle G, Tatum E. 1941. Genetic control of biochemical reactions in Neurospora. Proc. Natl. Acad. Sci. USA 27:499-506
10. Bellinger-Kawahara CG, Kempner E, Groth DF, Gabizon R, Prusiner SB. 1988. Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da. Virology 164:537-41
11. Bendheim PE, Barry RA, DeArmond SJ, Stites DP, Prusiner SB. 1984. Antibodies to a scrapie prion protein. Nature 310:418-21
12. Bessen RA, Marsh RF. 1994. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68:7859-68
13. Bolton DC, McKinley MP, Prusiner SB. 1982. Identification of a protein that purifies with the scrapie prion. Science 218:1309-11
14. Brenner S, Jacob F, Meselson M. 1961. An unstable intermediate carrying information from genes to ribosomes for protein synthesis. Nature 190:576-81
15. Browning SR, Mason GL, Seward T, Green M, Eliason GA, et al. 2004. Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP. J. Virol. 78:13345-50
16. Bruce ME. 2003. TSE strain variation: an investigation into prion disease diversity. Br. Med. Bull. 66:99-108
17. Bruce ME, Dickinson AG. 1987. Biological evidence that the scrapie agent has an independent genome. J. Gen. Virol. 68:79-89
18. Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, et al. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73:1339-47
19. Carlson GA, Ebeling C, Yang SL, Telling G, Torchia M, et al. 1994. Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc. Natl. Acad. Sci. USA 91:5690-94
20. Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, et al. 1986. Linkage of prion protein and scrapie incubation time genes. Cell 46:503-11
21. Carlson GA, Westaway D, Goodman PA, Peterson M, Marshall ST, Prusiner SB. 1988. Genetic control of prion incubation period in mice. In Novel Infectious Agents and the Central Nervous System, Ciba Found. Symp. 135, ed. G Bock, J Marsh, pp. 84-99. Chichester, UK: Wiley
22. Chandler RL. 1961. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1:1378-79
23. Chesebro B. 2003. Introduction to the transmissible spongiform encephalopathies or prion diseases. Br. Med. Bull. 66:1-20
24. Chesebro B. 2004. Biomedicine. A fresh look at BSE. Science 305:1918-21
25. Chesebro B, Race R, Wehrly K, Nishio J, Bloom M, et al. 1985. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315:331-33
26. Crozet C, Bencsik A, Flamant F, Lezmi S, Samarut J, Baron T. 2001. Florid plaques in ovine PrP transgenic mice infected with an experimental ovine BSE. EMBO Rep. 2:952-56
27. Crozet C, Flamant F, Bencsik A, Aubert D, Samarut J, Baron T. 2001. Efficient transmission of two different sheet scrapie isolates in transgenic mice expressing the ovine PrP gene. J. Virol. 75:5328-34
28. Cuillé J, Chelle PL. 1939. Experimental transmission of trembling to the goat. C.R. Seances Acad. Sci. 208:1058-60
29. Dawson MH. 1930. The transformation of pneumococcal types. II. The inconvertibility of type-specific S pneumococci. J. Exp. Med. 51:123-47
30. Dawson MH, Sia RHP. 1931. in vitro transformation of pneumococcal types. I. A technique for inducing transformation of pneumococcal types in vitro. J. Exp. Med. 54:681-99
31. DeArmond SJ, McKinley MP, Barry RA, Braunfeld MB, McColloch JR, Prusiner SB. 1985. Identification of prion amyloid filaments in scrapie-infected brain. Cell 41:221-35
32. Diener TO, McKinley MP, Prusiner SB. 1982. Viroids and prions. Proc. Natl. Acad. Sci. USA 79:5220-24
33. Diringer H, Gelderblom H, Hilmert H, Ozel M, Edelbluth C, Kimberlin RH. 1983. Scrapie infectivity, fibrils and low molecular weight protein. Nature 306:476-78
34. Diringer H, Rahn HC, Bade L. 1984. Antibodies to protein of scrapie-associated fibrils. Lancet 2:345
35. Donne DG, Viles JH, Groth D, Mehlhorn I, James TL, et al. 1997. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl. Acad. Sci. USA 94:13452-57
36. Dubos R, Avery OT. 1931. Decomposition of the capsular polysaccharide of pneumococcus type III by a bacterial enzyme. J. Exp. Med. 54:51-71
37. Dubos RJ. 1976. The Professor, the Institute, and DNA. New York: Rockefeller Univ. Press. 238 pp.
38. Gabizon R, McKinley MP, Groth D, Prusiner SB. 1988. Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl. Acad. Sci. USA 85:6617-21
39. Gabizon R, McKinley MP, Prusiner SB. 1987. Purified prion proteins and scrapie infectivity copartition into liposomes. Proc. Natl. Acad. Sci. USA 84:4017-21
40. Gard S. 1940. Encephalomyelitis of mice. II. A method for the measurement of virus activity. J. Exp. Med. 72:69-77
41. Gordon WS. 1946. Advances in veterinary research. Vet. Res. 58:516-20
42. Govaerts C, Wille H, Prusiner SB, Cohen FE. 2004. Evidence for assembly of prions with left-handed β-helices into trimers. Proc. Natl. Acad. Sci. USA 101:8342-47
43. Griffith F. 1928. Significance of pneumococcal types. J. Hygiene 27:113-59
44. Griffith JS. 1967. Self-replication and scrapie. Nature 215:1043-44
45. Haurowitz F. 1950. Protein synthesis. In Chemistry and Biology of Proteins, pp. 326-58. New York: Academic
46. Hershey AD, Chase M. 1952. Independent functions of viral protein and nucleic acid in growth of bacteriophage. J. Gen. Physiol. 36:39-56
47. Hill AF, Antoniou M, Collinge J. 1999. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 80:11-14
48. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, et al. 1989. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 338:342-45
49. Hsiao KK, Groth D, Scott M, Yang SL, Serban H, et al. 1994. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl. Acad. Sci. USA 91:9126-30
50. Hunter GD. 1972. Scrapie: a prototype slow infection. J. Infect. Dis. 125:427-40
51. Kaneko K, Ball HL, Wille H, Zhang H, Groth D, et al. 2000. A synthetic peptide initiates Gerstmann-Sträussler-Scheinker (GSS) disease in transgenic mice. J. Mol. Biol. 295:997-1007
52. Kellings K, Meyer N, Mirenda C, Prusiner SB, Riesner D. 1992. Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocussing gel electrophoresis (RRGE). J. Gen. Virol. 73:1025-29
53. Kimberlin RH. 1982. Scrapie agent: prions or virinos? Nature 297:107-8
54. King CY, Diaz-Avalos R. 2004. Protein-only transmission of three yeast prion strains. Nature 428:319-23
55. Kornberg A, Baker TA. 1992. DNA Replication. New York: WH Freeman. 931 pp.
56. Korth C, Kaneko K, Groth D, Heye N, Telling G, et al. 2003. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc. Natl. Acad. Sci. USA 100:4784-89
57. Legname G, Baskakov IV, Nguyen HOB, Riesner D, Cohen FE, et al. 2004. Synthetic mammalian prions. Science 305:673-76
58. Levene PA, Dillon RT. 1932. Intestinal nucleotidase and polynucleotidase. J. Biol. Chem. 96:461-77
59. Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ. 2002. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl. Acad. Sci. USA 99:7402-7
60. Manuelidis L. 1996. In the community of dinosaurs: the viral view. In Transmissible Subacute Spongiform Encephalopathies: Prion Diseases, ed. L Court, B Dodet, pp. 375-87. Paris: Elsevier
61. Marsh RF, Kimberlin RH. 1975. Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology and pathogeriesis. J. Infect. Dis. 131:104-10
62. McCarty M. 1946. Purification and properties of desoxyribonuclease isolated from beef pancreas. J. Gen. Physiol. 29:123-39
63. McCarty M. 1985. The Transforming Principle: Discovering that Genes Are Made of DNA. New York: Norton. 252 pp.
64. McCarty M. 1994. A retrospective look: how we identified the pneumococcal transforming substance as DNA. J. Exp. Med. 179:385-94
65. McCarty M, Avery OT. 1946. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. II. Effect of desoxyribonuclease on the biological activity of the transforming substance. J. Exp. Med. 83:89-96
66. McCarty M, Avery OT. 1946. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. III. An improved method for the isolation of the transforming substance and its application to pneumococcus Types II, III, and VI. J. Exp. Med. 83:97-104
67. McKinley MP, Bolton DC, Prusiner SB. 1983. A protease-resistant protein is a structural component of the scrapie prion. Cell 35:57-62
68. McKinley MP, Meyer RK, Kenaga L, Rahbar F, Cotter R, et al. 1991. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J. Virol. 65:1340-51
69. Mehlhornl, Groth D, Stockel J, Moffat B, Reilly D, et al. 1996. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 35:5528-37
70. Meselson M, Stahl FW. 1958. The replication of DNA in Escherichia coli. Proc. Natl. Acad. Sci. USA 44:671-82
71. Millson GC, Hunter GD, Kimberlin RH. 1976. The physico-chemical nature of the scrapie agent. In Slow Virus Diseases of Animals and Man, ed. RH Kimberlin, pp. 243-66. New York: Am. Elsevier
72. Mirsky AE, Pollister AW. 1946. Chromosin, a desoxyribose nucleoprotein complex of the cell nucleus. J. Gen. Physiol. 30:117-48
73. Mirsky AE, Ris H. 1949. Variable and constant components of chromosomes. Nature 163:666-67
74. Morona JK, Morona R, Paton JC. 1997. Molecular and genetic characterization of the capsule biosynthesis locus of Streptococcuspneumoniae type 19B. J. Bacteriol. 179:4953-58
75. Narang H. 2002. A critical review of the nature of the spongiform encephalopathy agent: protein theory versus virus theory. Exp. Biol. Med. 227:4-19
76. Neufeld F, Levinthal W. 1928. Beiträge zur Variabilität der Pneumokokken. Z. Immunitätsforsch. 55:324-40
77. Nirenberg M, Leder P. 1964. RNA codewords and protein synthesis. The effect of trinucleotides upon the binding of sRNA to ribosomes. Science 145:1399-407
78. Oesch B, Westaway D, Wälchli M, McKinley MP, Kent SBH, et al. 1985. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40:735-46
79. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, et al. 1993. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90:10962-66
80. Pattison IH. 1988. Fifty years with scrapie: a personal reminiscence. Vet. Rec. 123:661-66
81. Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, et al. 2002. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34:921-32
82. Peterson SN, Sung CK, Cline R, Desai BV, Snesrud EC, et al. 2004. Identification of competence pheromone responsive genes in Streptococcus pneumoniae by use of DNA microarrays. Mol. Microbiol. 51:1051-70
83. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-44
84. Prusiner SB. 1989. Scrapie prions. Annu. Rev. Microbiol. 43:345-74
85. Prusiner SB. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-83
86. 85a. Prusiner SB, ed. 2004. Prion Biology and Diseases. Cold Spring Harbor: Cold Spring Harbor Lab. Press
87. Prusiner SB, Bolton DC, Groth DF, Bowman KA, Cochran SP, McKinley MP. 1982. Further purification and characterization of scrapie prions. Biochemistry 21:6942-50
88. Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, Martinez HM. 1982. Measurement of the scrapie agent using an incubation time interval assay. Ann. Neurol. 11:353-58
89. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, et al. 1993. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl. Acad. Sci. USA 90:10608-12
90. Prusiner SB, Groth DF, Bildstein C, Masiarz FR, McKinley MP, Cochran SP. 1980. Electrophoretic properties of the scrapie agent in agarose gels. Proc. Natl. Acad. Sci. USA 77:2984-88
91. Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE. 1984. Purification and structural studies of a major scrapie prion protein. Cell 38:127-34
92. Prusiner SB, Groth DF, Cochran SP, Masiarz FR, McKinley MP, Martinez HM. 1980. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 21:4883-91
93. Prusiner SB, Hadlow WJ, Garfin DE, Cochran SP, Baringer JR, et al. 1978. Partial purification and evidence for multiple molecular forms of the scrapie agent. Biochemistry 17:4993-97
94. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, et al. 1983. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35:349-58
95. Prusiner SB, McKinley MP, Groth DF, Bowman KA, Mock NI, et al. 1981. Scrapie agent contains a hydrophobic protein. Proc. Natl. Acad. Sci. USA 78:6675-79
96. Prusiner SB, Safar J, DeArmond SJ. 2004. Bioassays of prions. See Ref. 85-a, pp. 143-86
97. Prusiner SB, Scott M, Foster D, Pan KM, Groth D, et al. 1990. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63:673-86
98. Riek R, Hornemann S, Wider G, Glockshuber R, Wuthrich K. 1997. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 413:282-88
99. Rohwer RG. 1991. The scrapie agent: "a virus by any other name". Curr. Top. Microbiol. Immunol. 172:195-232
100. Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, et al. 2005. Search for a prion-specific nucleic acid. J. Virol. 79:10796-806
101. Scott MR, Safar J, Telling G, Nguyen O, Groth D, et al. 1997. Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. Proc. Natl. Acad. Sci. USA 94:14279-84
102. Sevag MG. 1934. Eine neue physikalische Enteiweissungsmethode zur Darstellung biologisch Wirksamen Substanzen. Biochem. Z. 273:419 102.
103. Sia RHP, Dawson MH. 1931. In vitro transformation of pneumococcal types. II. The nature of the factor responsible for the transformation of pneumococcal types. J. Exp. Med. 54:701-10
104. ÷] factor by in vitro-converted Sup35 protein. Science 289:595-99
105. Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, et al. 1993. Structural analysis of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32:1991-2002
106. Stanley WM. 1935. Isolation of a crystalline protein possessing the properties of tobacco mosaic virus. Science 81:644-45
107. Stanley WM. 1970. The "undiscovered" discovery. Arch. Environ. Health 21:256-62
108. Supattapone S, Muramoto T, Legname G, Mehlhorn I, Cohen FE, et al. 2001. Identification of two prion protein regions that modify scrapie incubation time. J. Virol. 75:1408-13
109. Tagliavini F, Prelli F, Ghiso J, Bugiani O, Serban D, et al. 1991. Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J. 10:513-19
110. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. 2004. Conformational variations in an infectious protein determine prion strain differences. Nature 428:323-28
111. Telling GC, Haga T, Torchia M, Tremblay P, DeArmond SJ, Prusiner SB. 1996. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev. 10:1736-50
112. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, et al. 1996. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079-82
113. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, et al. 1995. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83:79-90
114. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, et al. 2001. Complete genome sequence of a virulent isolate of Streptococcuspneumoniae. Science 293:498-506
115. Sc conformers induced by a synthetic peptide and several prion strains. J. Virol. 78:2088-99
116. Vilotte JL, Soulier S, Essalmani R, Stinnakre MG, Vaiman D, et al. 2001. Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine PrP. J. Virol. 75:5977-84
117. Watson JD, Crick FHC. 1953. Genetical implication of the structure of deoxyribose nucleic acid. Nature 171:964-67
118. Watson JD, Crick FHC. 1953. A structure for deoxyribose nucleic acids. Nature 171:737-38
119. Weissmann C. 1991. A "unified theory" of prion propagation. Nature 352:679-83
120. Wickner RB. 1994. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264:566-69
121. Will RG, Alpers MP, Dormont D, Schonberger LB. 2004. Infectious and sporadic prion diseases. See Ref. 85a, pp. 629-71
122. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, et al. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-25
123. Yanofsky C, Carlton BC, Guest JR, Helinski DR, Henning U. 1964. On the colinearity of gene structure and protein structure. Proc. Natl. Acad. Sci. USA 51:266-72